Evidence map›Paper›PMID 38809989›Full record

ArticleScience advances2024

Luke R Joyce, Sol Kim, Brady L Spencer, Priya M Christensen, Kelli L Palmer, Ziqiang Guan, Julie A Siegenthaler, Kelly S Doran

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. A cross-strain CRISPRi sgRNA library forMicrobiology resource announcements · 2026
    Article
  5. Article
  6. CorAVeterinary research · 2026
    Article
  7. CRISPR interference in aJournal of bacteriology · 2026
    Article
  8. Article
  9. Identification of glyoxalase A in group BInfection and immunity · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Identification of Glyoxalase A in Group BbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luke R JoyceDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0002-9346-671X
Sol KimDepartment of Pediatrics, Section of Developmental Biology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0002-5037-5068
Brady L SpencerDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0003-4374-6403
Priya M ChristensenDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, TX, USA.ORCID 0000-0003-4790-9839
Kelli L PalmerDepartment of Biological Sciences, The University of Texas at Dallas, Richardson, TX, USA.ORCID 0000-0002-7343-9271
Ziqiang GuanDepartment of Biochemistry, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0002-8082-3423
Julie A SiegenthalerDepartment of Pediatrics, Section of Developmental Biology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0003-3700-6441
Kelly S DoranDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0003-4232-6837

Funding

Retinoic Acid in Development of CNS VasculatureR01NS098273 · NINDS · UNIVERSITY OF COLORADO DENVER · PI SIEGENTHALER, JULIE · 2016 to 2025
$3.2M
Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tractR01AI153332 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DORAN, KELLY S · 2021 to 2025
$2.9M
Roles of novel cationic lipids in bacterial pathogenesisR01AI178692 · NIAID · UNIVERSITY OF TEXAS DALLAS · PI Kelly S Doran, Ziqiang Guan · 2023 to 2026
$2.6M
Adaptive alterations of lipids in mitis group streptococciR01AI148366 · NIAID · UNIVERSITY OF TEXAS DALLAS · PI GUAN, ZIQIANG, PALMER, KELLI LEA · 2020 to 2024
$2.5M
Modulation of Blood-Brain Barrier Defense and Dysfunction during Bacterial MeningitisR01NS116716 · NINDS · UNIVERSITY OF COLORADO DENVER · PI DORAN, KELLY S · 2020 to 2024
$1.9M
NIAID NIH HHS R01 AI148366NIAID NIH HHS R01 AI153332NIAID NIH HHS R01 AI178692NINDS NIH HHS R01 NS098273NINDS NIH HHS R01 NS116716
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlycolipidsStreptococcal InfectionsStreptococcus agalactiaeAnimalsDisease Models, AnimalHost-Pathogen InteractionsHumansMiceMutationNeutrophilsVirulenceGlycolipids

Identifiers

PMID38809989
PMCPMC11135403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.